Ipca Laboratories Limited (IPCALAB.NS)
INR 1368.0
(2.78%)
INR 1368.0
(2.78%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 14.38 Billion INR | -2.9% |
| 2022 | 14.81 Billion INR | 83.5% |
| 2021 | 8.07 Billion INR | 204.16% |
| 2020 | 2.65 Billion INR | -47.0% |
| 2019 | 5 Billion INR | 7.69% |
| 2018 | 4.64 Billion INR | -25.91% |
| 2017 | 6.27 Billion INR | -12.32% |
| 2016 | 7.15 Billion INR | -10.88% |
| 2015 | 8.03 Billion INR | -14.1% |
| 2014 | 9.34 Billion INR | 55.17% |
| 2013 | 6.02 Billion INR | -2.35% |
| 2012 | 6.17 Billion INR | 16.08% |
| 2011 | 5.31 Billion INR | 0.14% |
| 2010 | 5.3 Billion INR | 16.79% |
| 2009 | 4.54 Billion INR | -1.18% |
| 2008 | 4.59 Billion INR | 30.29% |
| 2007 | 3.53 Billion INR | 47.74% |
| 2006 | 2.38 Billion INR | 21.35% |
| 2005 | 1.96 Billion INR | -10.8% |
| 2004 | 2.2 Billion INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 19.87 Billion INR | 0.0% |
| 2023 FY | 14.38 Billion INR | -2.9% |
| 2023 Q4 | 14.38 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 7.33 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 14.81 Billion INR | 0.0% |
| 2022 FY | 14.81 Billion INR | 83.5% |
| 2021 Q4 | 8.07 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 3.06 Billion INR | 0.0% |
| 2021 FY | 8.07 Billion INR | 204.16% |
| 2020 Q4 | 2.65 Billion INR | 0.0% |
| 2020 FY | 2.65 Billion INR | -47.0% |
| 2020 Q2 | 3.34 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 5 Billion INR | 7.69% |
| 2019 Q4 | 5 Billion INR | 0.0% |
| 2019 Q2 | 4.58 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q4 | 4.64 Billion INR | 0.0% |
| 2018 FY | 4.64 Billion INR | -25.91% |
| 2018 Q1 | - INR | 0.0% |
| 2017 FY | 6.27 Billion INR | -12.32% |
| 2016 FY | 7.15 Billion INR | -10.88% |
| 2015 FY | 8.03 Billion INR | -14.1% |
| 2014 FY | 9.34 Billion INR | 55.17% |
| 2013 FY | 6.02 Billion INR | -2.35% |
| 2012 FY | 6.17 Billion INR | 16.08% |
| 2011 FY | 5.31 Billion INR | 0.14% |
| 2010 FY | 5.3 Billion INR | 16.79% |
| 2009 FY | 4.54 Billion INR | -1.18% |
| 2008 FY | 4.59 Billion INR | 30.29% |
| 2007 FY | 3.53 Billion INR | 47.74% |
| 2006 FY | 2.38 Billion INR | 21.35% |
| 2005 FY | 1.96 Billion INR | -10.8% |
| 2004 FY | 2.2 Billion INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Hester Biosciences Limited | 2.44 Billion INR | -488.58% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -2112.984% |
| Aarti Drugs Limited | 5.64 Billion INR | -154.906% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | -404.245% |
| Albert David Limited | 33.24 Million INR | -43169.359% |
| Alembic Limited | 91.5 Million INR | -15619.781% |
| Alkem Laboratories Limited | 14.18 Billion INR | -1.407% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | -180.295% |
| Bafna Pharmaceuticals Limited | 243.89 Million INR | -5797.504% |
| Bajaj HealthCare Limited | 3.32 Billion INR | -332.168% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -327619.298% |
| Brooks Laboratories Limited | 56.41 Million INR | -25394.248% |
| Eris Lifesciences Limited | 27.81 Billion INR | 48.284% |
| FDC Limited | 205.18 Million INR | -6910.064% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -8287.917% |
| Gufic Biosciences Limited | 3.32 Billion INR | -332.049% |
| Hikal Limited | 8.17 Billion INR | -75.929% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -8553.559% |
| Ind-Swift Limited | 10.13 Billion INR | -41.851% |
| Innova Captab Limited | 2.45 Billion INR | -486.837% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -4290.598% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -15987.239% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 60.743% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -4445.084% |
| Laurus Labs Limited | 25.77 Billion INR | 44.193% |
| Lincoln Pharmaceuticals Limited | 10.66 Million INR | -134729.396% |
| Lupin Limited | 29.21 Billion INR | 50.771% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -1360.375% |
| Medico Remedies Limited | 80.5 Million INR | -17766.938% |
| Morepen Laboratories Limited | 289.99 Million INR | -4859.999% |
| Nectar Lifesciences Limited | 6.35 Billion INR | -126.322% |
| Orchid Pharma Limited | 1.35 Billion INR | -964.028% |
| Procter & Gamble Health Limited | 95.6 Million INR | -14945.607% |
| Sigachi Industries Limited | 1.43 Billion INR | -905.483% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | -42.201% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 56.063% |
| Themis Medicare Limited | 957.92 Million INR | -1401.542% |
| Unichem Laboratories Limited | 2.47 Billion INR | -481.122% |
| Vaishali Pharma Limited | 134.91 Million INR | -10560.994% |
| Venus Remedies Limited | 413.3 Million INR | -3380.184% |
| Wanbury Limited | 1.16 Billion INR | -1134.807% |
| Windlas Biotech Limited | 36.41 Million INR | -39404.532% |
| ZIM Laboratories Limited | 1.08 Billion INR | -1221.726% |
| Sakar Healthcare Limited | 793.51 Million INR | -1712.641% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 78.363% |
| Divi's Laboratories Limited | 30 Million INR | -47845.333% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -31180.936% |
| Mankind Pharma Limited | 2.07 Billion INR | -594.282% |
| Sequent Scientific Limited | 4.87 Billion INR | -194.931% |
| Neuland Laboratories Limited | 953.89 Million INR | -1407.879% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | -280.861% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | -16.851% |
| Zydus Lifesciences Limited | 8.04 Billion INR | -78.856% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -83123.977% |
| Wockhardt Limited | 23.56 Billion INR | 38.949% |
| Bal Pharma Limited | 1.39 Billion INR | -929.987% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 28.154% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -1340.664% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 19.7 Million INR | -72913.198% |
| Shilpa Medicare Limited | 9.37 Billion INR | -53.443% |
| Valiant Laboratories Limited | 767.08 Million INR | -1775.101% |
| Ajanta Pharma Limited | 352.8 Million INR | -3976.984% |
| Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | -4487.732% |
| Granules India Limited | 13.15 Billion INR | -9.376% |
| Medicamen Biotech Limited | 308.17 Million INR | -4567.394% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -1884.312% |
| Piramal Enterprises Limited | 535.85 Billion INR | 97.316% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 64.238% |
| NATCO Pharma Limited | 3.71 Billion INR | -287.489% |
| Suven Life Sciences Limited | 7.09 Million INR | -202571.551% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -643.609% |
| Strides Pharma Science Limited | 25.16 Billion INR | 42.851% |
| Indoco Remedies Limited | 6.71 Billion INR | -114.054% |
| Alpa Laboratories Limited | 52.46 Million INR | -27315.61% |
| Lasa Supergenerics Limited | 220.76 Million INR | -6415.433% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -2252.183% |